| Net Cash Provided by (Used in) Operating Activities |
$4,141,000 |
USD |
-184% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,406,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,173,000 |
USD |
56% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,908,000 |
USD |
66% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$756,000 |
USD |
-58% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$103,884,000 |
USD |
9.2% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$103,884,000 |
USD |
9.2% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$31,610,000 |
USD |
-17% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$1,173,000 |
USD |
-57% |
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$41,247,000 |
USD |
-19% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$2,462,000 |
USD |
12% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$3,848,000 |
USD |
-1.5% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$3,932,000 |
USD |
2.7% |
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$9,637,000 |
USD |
-24% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$3,757,000 |
USD |
-3.8% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$14,330,000 |
USD |
28% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$3,659,000 |
USD |
-6.7% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$180,100,000 |
USD |
33% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
$8,058,000 |
USD |
465% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |